Bud Nelson

Dr. Nelson has extensive experience in intellectual property protection, technology development and management, and in general corporate legal matters. In addition to his role at Cellective, he serves as Chief Intellectual Property Counsel of Istari Oncology, Inc.; Director of Operations of DILIsym Services, Inc., and General Counsel and Chief Technology Officer of MedBlue Incubator, Inc. His previous positions were senior leadership roles at several life sciences, biotechnology, and medical device companies, including Vice President of BioCrystal Ltd.; Chief Intellectual Property and Corporate Counsel of Trimeris, Inc.; Vice President, Corporate Counsel and Director of Intellectual Property of Affinergy, Inc.; Chief Intellectual Property Counsel of b3Bio, Inc.; General Counsel, Executive Director, Technology Development and Co-Managing Director of The Hamner BioSciences Accelerator of The Hamner Institutes; and a member of the board of directors of DILisym Services, Inc. He holds a JD degree and a Ph.D. degree in immunology and microbiology, both from the University of Buffalo.